Jointly provided by Impact Education, LLC and Postgraduate Institute for Medicine.     This activity is supported by independent educational grants from Celgene Corporation and Sanofi Genzyme. Monday, April 23, 2018 6:00 PM - 8:00 PM Boston Convention and Exhibition Center Room 109AB Boston, MA Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018 is required. Held in conjunction with AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018. Click here to download the slides from this symposium. Don't miss the live webcast, "Managing Multiple Sclerosis: Current Treatment and Care Management Strategies for Managed Care Live Webcast". Click here to register and for full accreditation information.   Hot Topics Review of recently approved and emerging therapies Quality standards, health care policy, and benefit designs to enhance outcomes Care pathways to manage and improve economic outcomes Health coaching strategies to enhance patient engagement Key Insights from Leading Patient Advocacy Association, MSAA   Expert Faculty Presenters James Kenney, Jr., RPh, MBA Manager, Specialty and Pharmacy Contracts Harvard Pilgrim Health Care Edmund Pezalla, MD, MPH CEO Enlightenment Bioconsult, LLC Harold Moses, Jr., MD Associate Professor of Neurology Neuroimmunology Division Vanderbilt University Kyle Pinion Director of Public Policy & Advocacy Southeast Regional Director Multiple Sclerosis Association of America   Who Should Attend? This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP 2018 Managed Care and Specialty Pharmacy Annual Meeting.   Statement of Need/Program Overview Multiple sclerosis (MS) is a complex disease that requires a collaborative approach to care to achieve optimal patient care and outcomes. Disease-modifying therapies (DMTs) are a core component of MS management. Due to a lack of head-to-head trials it is difficult to determine which therapy would be most effective for MS; however, it is possible to evaluate current therapies based on their effects on sustained disability, relapse rate, lesion load, brain atrophy, and cognitive dysfunction. Members of the clinical team, as well as patients, need to coordinate these efforts when choosing the appropriate therapy and continually monitor the disease while managing symptoms and the psychological aspects of the disease. Therefore, it is important for specialty pharmacists and other managed care professionals to be aware of and engaged in the care and treatment of patients with MS. The activity will consist of three expert faculty demonstrating the unique value each brings to the overall care of patients through real world examples and case studies. By working together via data sharing and collaboration between payers, clinicians, specialty pharmacy, and patients, on a more integrated approach, current barriers will be overcome, demonstrating value to all parties and motivating them to become further engaged.   Educational Objectives At the conclusion of this activity, participants should be able to demonstrate improved ability to: Review recent insights into the safety, efficacy, and attributes of emerging MS therapies Apply managed care MS treatment algorithms with recent clinical trial data Analyze care pathways and their application to manage economic outcomes in MS Employ health coaching strategies to enhance MS patient engagement in their care   Agenda Date and Time Monday, April 23, 2018 6:00 PM - 8:00 PM Boston Convention and Exhibition Center Room 109AB Boston, MA Please note that Specialty Connect will take place at the The Westin Boston Waterfront Hotel, however, the MS symposium will be at the Boston Convention Center and Exhibition Center in room 109B 6:00 PM Pre-Activity Learning Assessment and Opening Comments/Overview 6:05 PM Clinical Update: Current Insights into MS Treatment Harold Moses, Jr., MD 6:40 PM MS Care Pathways and Algorithms to Improve Clinical and Economic Outcomes Edmund Pezalla, MD, MPH 7:15 PM Health Coaching Strategies for Optimal MS Management James Kenney, Jr., RPh, MBA 7:40 PM Patient Perspective - MSAA Overview Kyle Pinion 7:45 PM Audience Q&A Session 7:55 PM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation 8:00 PM Adjournment   Accreditation Information Joint Accreditation Statement In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Physician Continuing Medical Education The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Pharmacy Education Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008162-9999-18-045-L01-P Type of Activity: Application For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from CEcertificate@pimed.com within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service. Please note: Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required. Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. Americans with Disabilities Act ♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812. Fee Information No additional fee is required to attend this CPE/CME activity. Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018 is required. Pre-registration will close at 12:00 pm on April 22, 2018. Walk-in registration will be available at the time of the program. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.